Faculty

Institution

Unit

Venue

Joshua Warrick

Pennsylvania State University

Affiliations

Penn State College of Medicine

Department of Pathology and Laboratory Medicine

Department of Urology

Department of Pathology and Laboratory Medicine

Division of Anatomic Pathology

NoneJoshua Warrick is currently serving as a Pathology And Laboratory Medicine faculty at Pennsylvania State University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Joshua Warrick

Pennsylvania State University

You can click a keyword to filter the displayed items

urology oncology bladder cancer cancer research cancer biology tumor biology pathology genetics cancer genomics genitourinary cancers molecular biology cancer cells gene expression medicinal research cancer genetics carcinogenesis molecular cancer oncogenes cancer treatment cancer care breast cancer cancer discovery histopathology molecular pathology prostate cancer vascular biology tumor targeting clinical pathology surgical pathology tumor heterogeneity transcription regulation prostatic disease leukemia gynecologic oncology respiratory medicine radiation therapy cancer risk cancer management tumoral pathology urological research histologic variants concurrent durvalumab adjuvant durvalumab cellular therapy clinical otolaryngology laboratory medicine human pathology otorhinolaryngology epigenomics gene function mutagenesis clinical evidence endocrine oncology reconstructive urology squamous differentiation molecular subtypes brain tumor research pathway analysis prognosis somatic variant benign prostatic hyperplasia clinical populations variant interpretation clinical presentation retrospective cohort studies clinical significance localized urothelial cancer urothelial carcinoma malpractice climate urinary bladder phase ib study human cell lines non-muscle-invasive bladder cancer intratumoral heterogeneity pparg cooperate molecular analysis cancer letter metabolomic profiling omics metabolomics thyroid neoplasms

Notable Scholarly Works

Notable Federal Grants

Collaborators

Ifnγ/Jak1/Stat1 Signaling Represses Foxa1 and Drives a Basal Transcriptional State in Muscle-Invasive Bladder Cancer. American Journal Of Pathology (2025)

Shamara S LawrenceHironobu YamashitaLauren ShumanJay D RamanMonika JoshiGregory S YochumXue-Ru WuHikmat A Al-AhmadieJoshua I WarrickVonn WalterDavid J DeGraff

signaling pathwaysgene expressiontranscription regulationbladder cancerbasal transcriptional statesystems biologycell signalingurologytranscription (biology)muscle-invasive bladder canceroncogenescancer cellssignal transductionpathologygene regulation

Cell Cycle Regulators as Oncogenic Drivers in Bladder Cancer. (2024)

David J. DeGraffXue-Ru WuJoshua I. WarrickShamara LawrenceMoon-Shong Tang

oncogenic driverscell cyclebladder cancercell cycle regulators

Clinicopathological Risk Factors Associated With Tumor Relapse of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy: A Single Institution 20-Year Experience. Annals of Diagnostic Pathology (2024)

Yong ZhangQingqing WuJoshua I. WarrickDavid J. DeGraffJay D. RamanHong TruongGuoli Chen

radical nephroureterectomyclinical pathologydiagnosistumor relapsepathologyclinicopathological risk factors

Management Options for Node-Positive Muscle-Invasive Bladder Cancer.. PubMed (2024)

Hyma V PolimeraPriyanka BhatiaMegan WheeldenStuthi PerimbetiJoshua WarrickMonika Joshi

medicinemanagement optionsbladder cancercancer carecancer managementurologyoncologycancer treatment

Molecular Subtypes of Bladder Cancer: Component Signatures and Potential Value in Clinical Decision-Making. Advances in Anatomic Pathology (2024)

Joshua Warrick

bladder cancermolecular subtypesanatomical pathologymolecular cancerurologypotential valuecomponent signaturesmolecular biologypathologymolecular pathology

Relationship Between Availability of Urologists and Primary Care Providers and Stage of Diagnosis for Invasive Urinary Bladder Cancer. Urology Practice (2024)

Joel E. SegelWilliam G. WongMatthew KaagMonika JoshiJoshua WarrickEugene J. LengerichChan Shen

diagnosisurologyprimary care providers

Aacc Guidance Document on Cervical Cancer Detection: Screening, Surveillance, and Diagnosis. The Journal of Applied Laboratory Medicine (2023)

Yusheng ZhuSarah FeldmanShuk On Annie LeungMichael H CreerJoshua WarrickNicole WilliamsStephen Mastorides

public healthmedicinelaboratory investigationlaboratory medicineveterinary medicineobstetrics and gynaecologylaboratory managementcervical cancer detectiononcologycancer screeningcervical cancerclinical epidemiologyrespiratory medicineaacc guidance documenthealth sciencescancer detectionlaboratory protocols

Clinical and Pathological Characteristics of Metastatic Tumors to the Urinary Bladder. Annals of Diagnostic Pathology (2023)

Wei HuangJoshua I. WarrickGuoli Chen

metastasisurinary bladderpathologytumor microenvironmenturological researchreconstructive urologybladder cancerpathological characteristicsclinical pathologyurologymetastatic tumorssurgical pathologytumor biologytumoral pathologyradiologythoracic oncologycancer discoveryhistopathologygenitourinary cancersoncologycancer cells

Concurrent Durvalumab and Radiation Therapy (Duart) Followed by Adjuvant Durvalumab in Patients With Localized Urothelial Cancer of Bladder: Results From Phase II Study, Btcrc-Gu15-023. Journal for ImmunoTherapy of Cancer (2023)

Monika JoshiLeonard TuanquinJunjia ZhuVonn WalterTodd SchellMatthew KaagDeepak KilariJiangang LiaoSheldon L HolderHamid EmamekhooAlexander SankinSuzzane MerrillHong ZhengJoshua WarrickRalph HaukeBenjamin GartrelMark SteinJoseph DrabickDavid J DegraffYousef Zakharia

concurrent durvalumabmedicinecancer managementradiation oncologyurologycancer immunotherapyphase ii studyoncologyadjuvant durvalumabradiation therapycancer treatmentlocalized urothelial cancerimmunotherapy

Defining the Clinical Characteristics of Mammary Analog Secretory Carcinoma of the Salivary Gland: Analysis of the National Cancer Database. SAGE Open Medicine (2023)

Akshilkumar PatelBrandon LaBargeTonya S KingSandeep PradhanJoshua WarrickNeerav Goyal

clinical evidencegynecologic oncologygastrointestinal oncologyneurologymedicinecancer careendocrine oncologycancer biologycancer researchsurgical oncologyveterinary medicinenational cancer databasesalivary glandstumor biologycarcinogenesismedical mycologyradiation oncologycancer imagingoncologyclinical characteristics

1
2
3
4
5
11
10 / page

Joshua Warrick

Pennsylvania State University

Affiliations

Penn State College of Medicine

Department of Pathology and Laboratory Medicine

Department of Urology

Department of Pathology and Laboratory Medicine

Division of Anatomic Pathology

NoneJoshua Warrick is currently serving as a Pathology And Laboratory Medicine faculty at Pennsylvania State University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Joshua Warrick

Pennsylvania State University

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Ifnγ/Jak1/Stat1 Signaling Represses Foxa1 and Drives a Basal Transcriptional State in Muscle-Invasive Bladder Cancer. American Journal Of Pathology (2025)

Shamara S LawrenceHironobu YamashitaLauren ShumanJay D RamanMonika JoshiGregory S YochumXue-Ru WuHikmat A Al-AhmadieJoshua I WarrickVonn WalterDavid J DeGraff

Cell Cycle Regulators as Oncogenic Drivers in Bladder Cancer. (2024)

David J. DeGraffXue-Ru WuJoshua I. WarrickShamara LawrenceMoon-Shong Tang

oncogenic driverscell cyclebladder cancercell cycle regulators

Yong ZhangQingqing WuJoshua I. WarrickDavid J. DeGraffJay D. RamanHong TruongGuoli Chen

radical nephroureterectomyclinical pathologydiagnosistumor relapsepathologyclinicopathological risk factors

Management Options for Node-Positive Muscle-Invasive Bladder Cancer.. PubMed (2024)

Hyma V PolimeraPriyanka BhatiaMegan WheeldenStuthi PerimbetiJoshua WarrickMonika Joshi

medicinemanagement optionsbladder cancercancer carecancer managementurologyoncologycancer treatment

Molecular Subtypes of Bladder Cancer: Component Signatures and Potential Value in Clinical Decision-Making. Advances in Anatomic Pathology (2024)

Joshua Warrick

bladder cancermolecular subtypesanatomical pathologymolecular cancerurologypotential valuecomponent signaturesmolecular biologypathologymolecular pathology

Relationship Between Availability of Urologists and Primary Care Providers and Stage of Diagnosis for Invasive Urinary Bladder Cancer. Urology Practice (2024)

Joel E. SegelWilliam G. WongMatthew KaagMonika JoshiJoshua WarrickEugene J. LengerichChan Shen

diagnosisurologyprimary care providers

Aacc Guidance Document on Cervical Cancer Detection: Screening, Surveillance, and Diagnosis. The Journal of Applied Laboratory Medicine (2023)

Yusheng ZhuSarah FeldmanShuk On Annie LeungMichael H CreerJoshua WarrickNicole WilliamsStephen Mastorides

Clinical and Pathological Characteristics of Metastatic Tumors to the Urinary Bladder. Annals of Diagnostic Pathology (2023)

Wei HuangJoshua I. WarrickGuoli Chen

Defining the Clinical Characteristics of Mammary Analog Secretory Carcinoma of the Salivary Gland: Analysis of the National Cancer Database. SAGE Open Medicine (2023)

Akshilkumar PatelBrandon LaBargeTonya S KingSandeep PradhanJoshua WarrickNeerav Goyal

1
2
3
4
5
11
10 / page

Similar Faculty Members

Wael Sakr

Institution

Wayne State University

iological traits

oncogene

Anil Parwani

Institution

Ohio State University

cancer informatics

biomedical informatics

Robert West

Institution

Stanford University

breast pathology

radiation oncology

Jiaoti Huang

Institution

Duke University

urology

prostate cancer

Matija Snuderl

Institution

New York University

cancer genetics

epigenetics

Pedram Argani

Institution

Johns Hopkins University

breast oncology

urology

Jonathan Said

Institution

University of California, Los Angeles

molecular pathology

pathology

Peter Gann

Institution

University of Illinois Chicago

biomarker

chemoprevention strategies

Xiaowei Xu

Institution

University of Pennsylvania

immunotherapy

extracellular vesicle-based biomarkers

Angelo De Marzo

Institution

Johns Hopkins University

urology

prostate cancer

Similar Faculty Members

Wael Sakr

Institution

Wayne State University

iological traits

oncogene

Anil Parwani

Institution

Ohio State University

cancer informatics

biomedical informatics

Robert West

Institution

Stanford University

breast pathology

radiation oncology

Jiaoti Huang

Institution

Duke University

urology

prostate cancer

Matija Snuderl

Institution

New York University

cancer genetics

epigenetics

Pedram Argani

Institution

Johns Hopkins University

breast oncology

urology

Jonathan Said

Institution

University of California, Los Angeles

molecular pathology

pathology

Peter Gann

Institution

University of Illinois Chicago

biomarker

chemoprevention strategies

Xiaowei Xu

Institution

University of Pennsylvania

immunotherapy

extracellular vesicle-based biomarkers

Angelo De Marzo

Institution

Johns Hopkins University

urology

prostate cancer